Skip to content
value.today

PharmaCann LLC

🇺🇸 Oak Park, Illinois, USAPharmaceuticalsFounded 2014
Total raised
$372 M
14 rounds on record
Latest round
$35 M
Mar 2024
First round on record
Sep 2014
Today
Private
No later event on record

Funding rounds

14 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of PharmaCann LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$35 MNo. 14$10 to $50 million

PharmaCann LLC: Raise no. 14, Mar 2024

Investors in this round

7 investors had bought by the notice of Apr 9, 2024: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $50 M offered; $15 M still to sell
Smallest investment taken
$1,000,000
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

equity, debt, optionsSEC
Dec 2023$10 MNo. 13$10 to $50 million

PharmaCann LLC: Raise no. 13, Dec 2023

Investors in this round

1 investor had bought by the notice of Apr 9, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$400,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Netshares Financial Services LLC (CRD 307532) · Houston, TexasSold in TX

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Nov 2023$5 MNo. 12$2 to $10 million

PharmaCann LLC: Raise no. 12, Nov 2023

Investors in this round

3 investors had bought by the notice of Apr 9, 2024: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Nov 2023$10 MNo. 11$10 to $50 million

PharmaCann LLC: Raise no. 11, Nov 2023

Investors in this round

1 investor had bought by the notice of Apr 9, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Apr 2023$7 MNo. 10$2 to $10 million

PharmaCann LLC: Raise no. 10, Apr 2023

Investors in this round

1 investor had bought by the notice of Apr 9, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$280,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Netshares Financial Services LLC (CRD 307532) · Houston, TexasSold in TX

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Apr 2023$13 MNo. 9$10 to $50 million

PharmaCann LLC: Raise no. 9, Apr 2023

Investors in this round

6 investors had bought by the notice of Apr 9, 2024: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $18 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Issuer terminated the investors ability to put more into the offering, therefore the remaining amount to be sold is $0.”

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Jun 2021$110 MNo. 8$50 to $250 million

PharmaCann LLC: Raise no. 8, Jun 2021

Investors in this round

1 investor had bought by the notice of Jun 25, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$110 M of $110 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$350,000
Finders' fees
none
Paid to its own people
$19,097,982 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • James Patrick Barry · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Canaccord Genuity, LLC (CRD 1020) · New York, New YorkSold in DE

Remarks in the notice

  • On fees: “fairness opinion fee.”
  • On the amounts: “The Option was purchased for $110,392,371, which was paid as dividend directly to issuer's stockholders through a paying agent.”
  • On the use of proceeds: “Aggregate; as a result of the pro rata distributions made to all stockholders.”

Signed by Brett Novey, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2021. Read the notice at the SEC.

optionsSEC
Mar 2021$32 MNo. 7$10 to $50 million

PharmaCann LLC: Raise no. 7, Mar 2021

Investors in this round

2 investors had bought by the notice of Mar 19, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $33 M offered; $1 M still to sell
Smallest investment taken
$15,000,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Unzicker · Executive Officer
  • Greg Cappelli · Director
  • John McCarthy · Director
  • Patrick Barry · Director
  • Stephen Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brett Novey, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2021. Read the notice at the SEC.

equitySEC
Sep 2020$36 MNo. 6$10 to $50 million

PharmaCann LLC: Raise no. 6, Sep 2020

Investors in this round

134 investors had bought by the notice of Nov 13, 2020: 134 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $36 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$174,764
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Unzicker · Executive Officer
  • Greg Cappelli · Director
  • JOHN McCARTHY · Director
  • Patrick Barry · Director
  • Stephen Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • GT SECURITIES, INC. (CRD 116012) · Los Angeles, CaliforniaSold in DE, IL, WI, and outside the US
  • ENTORO SECURITIES, LLC (CRD 35192) · Houston, TexasSold in CA, DE, FL, IL, NY, TN, TX

Remarks in the notice

  • On fees: “Variable rate from 1.5% - 4% for a portion of the equity purchased in the offering, based on a variety of factors.”
  • On the amounts: “Total offering amount increased from $25,000,000, due to an over-allotment.”

Signed by Brett Novey, Chief executive officer. Source: SEC Form D, newest notice filed Nov 13, 2020. Read the notice at the SEC.

equitySEC
May 2020$28 MNo. 5$10 to $50 million

PharmaCann LLC: Raise no. 5, May 2020

Investors in this round

1 investor had bought by the notice of Apr 9, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Patrick Patrick Unzicker · Executive Officer
  • Robert Patrick McQueen · Executive Officer
  • James Patrick Barry · Director
  • John Patrick Lord · Director
  • John Patrick McCarthy · Director
  • Lori Patrick Richards · Director
  • Stephen Patrick Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert McQueen, Chief Legal Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

debt, optionsSEC
Feb 2020$20 MNo. 4$10 to $50 million

PharmaCann LLC: Raise no. 4, Feb 2020

Investors in this round

75 investors had bought by the notice of May 11, 2020: 75 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $25 M offered; $5 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Novey · Executive Officer, Director
  • Daniel Roth · Executive Officer
  • Greg Cappelli · Director
  • JOHN McCARTHY · Director
  • Patrick Barry · Director
  • Stephen Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brett Novey, Chief executive officer. Source: SEC Form D, newest notice filed May 11, 2020. Read the notice at the SEC.

equitySEC
Jun 2018$22 MNo. 3$10 to $50 million

PharmaCann LLC: Raise no. 3, Jun 2018

Investors in this round

22 investors had bought by the notice of Jul 2, 2018: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $31 M offered; $9 M still to sell
Smallest investment taken
$500,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Illinois

People named in the notice

  • Teddy Scott · Executive Officer, Director
  • Stephen Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Teddy Scott, CEO and Manager. Source: SEC Form D, newest notice filed Jul 2, 2018. Read the notice at the SEC.

equitySEC
Jun 2015$25 MNo. 2$10 to $50 million

PharmaCann LLC: Raise no. 2, Jun 2015

Investors in this round

6 investors had bought by the notice of Dec 28, 2015: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Illinois

People named in the notice

  • Brad Leshnock · Executive Officer
  • Christina Leja · Executive Officer, Director, Promoter
  • John Leja · Executive Officer, Promoter
  • Norah Scott · Executive Officer, Director, Promoter
  • Teddy Scott · Executive Officer, Promoter
  • Stephen Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Teddy C. Scott, Ceo. Source: SEC Form D, newest notice filed Dec 28, 2015. Read the notice at the SEC.

equity, debt, optionsSEC
Sep 2014$20 MNo. 1$10 to $50 million

PharmaCann LLC: Raise no. 1, Sep 2014

Investors in this round

1 investor had bought by the notice of Oct 3, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Illinois

People named in the notice

  • Christina D Leja · Executive Officer, Director, Promoter
  • John A Leja · Executive Officer, Director, Promoter
  • Norah Scott · Executive Officer, Director, Promoter
  • Teddy C Scott · Executive Officer, Director, Promoter
  • Stephen G Schuler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Teddy C. Scott, Ceo. Source: SEC Form D, newest notice filed Oct 3, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • PharmaCann LLC chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Apr 2024

That is all the official record says: PharmaCann LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of PharmaCann LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 14 rounds above had up to 134 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by PharmaCann LLC
NameRoleNamed in
Brett NoveyExecutive officerApr 2024
Patrick Patrick UnzickerExecutive officerApr 2024
Robert Patrick McQueenExecutive officerApr 2024
Daniel Patrick RothExecutive officerApr 2023
David Patrick ChiovettiExecutive officerApr 2023
Patrick UnzickerExecutive officerMar 2021
Daniel RothExecutive officerMay 2020
Teddy ScottExecutive officerJul 2018
Brad LeshnockExecutive officerDec 2015
Christina LejaExecutive officerDec 2015
John LejaExecutive officerDec 2015
Norah ScottExecutive officerDec 2015
Christina D LejaExecutive officerOct 2014
John A LejaExecutive officerOct 2014
Teddy C ScottExecutive officerOct 2014
Brett NoveyDirectorApr 2024
James Patrick BarryDirectorApr 2024
John Patrick LordDirectorApr 2024
John Patrick McCarthyDirectorApr 2024
Lori Patrick RichardsDirectorApr 2024
Stephen Patrick SchulerDirectorApr 2024
Greg CappelliDirectorMar 2021
John McCarthyDirectorMar 2021
Patrick BarryDirectorMar 2021
Stephen SchulerDirectorMar 2021
JOHN McCARTHYDirectorNov 2020
Teddy ScottDirectorJul 2018
Christina LejaDirectorDec 2015
Norah ScottDirectorDec 2015
Christina D LejaDirectorOct 2014
John A LejaDirectorOct 2014
Stephen G SchulerDirectorOct 2014
Teddy C ScottDirectorOct 2014
Christina LejaPromoterDec 2015
John LejaPromoterDec 2015
Norah ScottPromoterDec 2015
Teddy ScottPromoterDec 2015
Christina D LejaPromoterOct 2014
John A LejaPromoterOct 2014
Teddy C ScottPromoterOct 2014